Antimalarials in systemic diseases;Los antimaláricos en las enfermedades sistémicas

Revista Clinica Espanola

Volumn 205, Issue 5, 2005, Pages 230-232

  Tutor Ureta, P ^a   Yebra Bango, M ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; DOLQUINE; HYDROXYCHLOROQUINE; MEPACRINE; METHOTREXATE;

ABDOMINAL DISTENSION; AGRANULOCYTOSIS; ANOREXIA; ARTICLE; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CORNEA DISEASE; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; LUPUS ERYTHEMATOSUS; NAUSEA; NEUROMUSCULAR DISEASE; PREGNANCY; PRURITUS; RETINA DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SKIN MANIFESTATION; URTICARIA; VOMITING;

EID: 20444473126     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13075574     Document Type: Article

References (37)

1. Leden I. Antimalarial drugs: 350 years. Scand J Rheumatol. 1981;10: 307-12.
2. Payne JF. A postgraduate lecture on lupus erythematosus. Clin J. 1894; 4:223-9.
3. Goldman L, Cole DP, Preston RH. Chloroquine diphosphate in treatment of discoid lupus erythematosus. JAMA. 1953;152:1428-9.
4. Cornbleet T. Discoid lupus erythematosus treatment with plaquenil. Arch Dermatol. 1956;73:572-5.
5. Davis JC, Klippel JH. Antimalarial and Immunosupressive Drugs. En: Lahita RG, editor. Systemic lupus erythematosus. 2nd ed. New York: Academic Press. A Division of Harcourt Brace & Company; 1999. p. 967-84.
6. Wallace DJ. Antimalarial therapies. En: Wallace DJ, Hahn BH editors. Dubois' lupus erythematosus. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 1996. p. 1117-39.
7. Van Beek MJ, Piette WW. Antimalarials. Dermatol Clin. 2001;19:147-60.
8. Wozniacka A, Carter A, McCauliffe DP. Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit. Lupus. 2002;11:71-81.
9. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2407-15.
10. Roman MJ, Shanker B, Davis A, Lockshin MD, Sammaritano L, Simantov R, et al. Prevalence and correlates of accelerated atheroscerosis in systemic lupus erythematosus. N Engl J Med. 2003;349:2399-406.
11. Wallace DJ, Linker-Israeli M, Metzger AL, Stecher VJ. The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE. Lupus. 1993;2:S13-5.
12. Petri M. Hydroxychloroquine use in the Baltimore lupus cohort: effects on lipìds, glucose and thrombosis. Lupus. 1996;5:S16-22.
13. Combe B, Gutiérrez M, Anaya JM, Sany J. Possible efficacy of hydroxychloroquine on accelerated nodulosis during methotrexate therapy for rheumatoid arthritis. J Rehumatol. 1993;20:755-6.
14. Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: Coxiella burnetti paradigm. J Infect Dis. 1992;166:1097-102.
15. Raoult D, Houpikian P, Dupont HT, Riss JM Arditi-Djiane J, Brouqui P. Comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arc Intern Med. 1999;159:167-73.
16. Yebra-Bango M, Vargas-Núñez JA, Gea-Banacloche JC, Romero-Pizarro Y. Tratamiento del lupus eritematoso sistémico. Rev Clin Esp. 1995;195:50-60.
17. Ruiz-Irastorza G, Khamashta MA, Castellino G, Hughes GRV. Systemic lupus erythematosus. Lancet. 2001;357:1027-32.
18. Ioannou Y, Isenberg DA. Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge. Postgrad Med J. 2002;78:599-606.
19. Dall'Era M, Davis JC. Systemic lupus erythematosus. How to manage, when to refer. Postgrad Med. 2003;114:31-7.
20. Wallace DJ. Antimalarials. The «real» advance in lupus. Lupus. 2001; 10:385-7.
21. D'Cruz D. Antimalarial therapy: a panacea for mild lupus? Lupus. 2001; 10:148-51.
22. Rahman P, Gladman DD, Urowitz MB. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Reumatol. 1998;25:1716-9.
23. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the Management of Rheumatoid Arthritis. Arthritis Rheum. 2002;46;328-46.
24. Kremer JM. Rational use of new and existin disease-modifying agents in rheumatoid arthritis. Ann Intern Med. 2001;134:695-706.
25. Mulero-Mendoza. Tratamiento de la artritis reumatoide. Rev Clin Esp. 2004;204:273-82.
26. Matteson EL. Current treatment strategies for rheumatoid arthritis. Mayo Clin Proc. 2000;75:69-74.
27. O'Dell JR. Drug therapy: therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350:2591-602.
28. Fox RJ, Dixon R, Guarrasi V, Krubel S. Treatment of primary Sjögren syndrome with hydroxychloroquine: a retrospective, open-label study. Lupus. 1996;5:S31-6.
29. Manoussakis MN, Moutsopoulos HM. Antimalarials in Sjögren syndrome the Greek experience. Lupus. 1996;5:S28-S30.
30. Zic JA, Horowitz DH, Arzubiaga C, King LE Jr. Treatment of cutaneous sarcoidosis with chloroquine: Review of the literature. Arch Dermatol. 1991;127:1034-40.
31. James WD, Dawson N, Rodman OG. The treatment of dermatomiositis with hydroxychloroquine. J Rheumatol. 1985;12:1214-6.
32. Olson NY, Lindsley CB. Adjuntive use of hydroxychloroquine in childhood dermatomyisitis. J Rheumatol 1989;16:1545-7.
33. The Canadian Hydroxycloroquine Study Group. A randomised study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. N Engl J Med. 1991;324:150-4.
34. Jiménez-Alonso J, Sabio JM, Carrillo-Alascio PL, Jiménez-Jáimez J, Ortego-Centeno N, Jiménez-Jáimez E, et al. Intolerancia a la hidroxicloroquina comercializada en España (Dolquine®) en pacientes con patología autoinmune. Rev Clin Esp. 2004;204:588-91.
35. Parke AL, Rothfield NF. Antimalarial drugs in pregnancy the North American experience. Lupus. 1996;5:S67-9.
36. Canadian Rheumatology Association. Canadian Consensus Conference on hidroxychloroquine. J Rheumatol 2000;27:2919-21.
37. Bucchanan NM, Toubi E, Khamashta MA, Lima F, Kerslake S, Hughes GR. Hydroxycloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis. 1996;55:486-8.